![conference banner](/images/conference-banner.jpeg)
Current Pharmaceutical Design
Title: Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)]
Volume: 9 Issue: 26
Author(s): L. H. Patterson
Affiliation:
Export Options
About this article
Cite this article as:
Patterson H. L., Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor : L.H. Patterson)], Current Pharmaceutical Design 2003; 9 (26) . https://dx.doi.org/10.2174/1381612033454081
DOI https://dx.doi.org/10.2174/1381612033454081 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis
Reviews on Recent Clinical Trials The Significance of Meat in the Diet
Current Nutrition & Food Science Patent Selections
Recent Patents on DNA & Gene Sequences A Review on the Phytochemicals, Ethnomedicine Uses and Pharmacology of Ficus Species
Current Traditional Medicine Potential of Gold Candidates against Human Colon Cancer
Mini-Reviews in Medicinal Chemistry IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Anticancer Metallotherapeutics in Preclinical Development
Current Medicinal Chemistry Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Current Molecular Pharmacology All for Statins and Statins for All; An Update
Current Pharmaceutical Design Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism Mitochondria-Targeting Anticancer Metal Complexes
Current Medicinal Chemistry Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy
Current Cancer Drug Targets Peptidic Compound as DNA Binding Agent: <i>In Silico</i> Fragment-based Design, Machine Learning, Molecular Modeling, Synthesis, and DNA Binding Evaluation
Protein & Peptide Letters Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-582-5p Reduces Propofol-induced Apoptosis in Developing Neurons by Targeting ROCK1
Current Neurovascular Research Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets Anti-Cancer Potential of Some Commonly Used Drugs
Current Pharmaceutical Design Ca<sup>2+</sup> Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
Current Vascular Pharmacology Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties
Current Topics in Medicinal Chemistry Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets